Eisai and Biogen Advance LEQEMBI SC for Alzheimer’s Disease
TOKYO, Japan / CAMBRIDGE, Massachusetts, USA, July 12, 2026 Eisai Co., Ltd. and Biogen Inc. have announced new clinical...
FDA Cleared
Advertisement
Theranica Expands Nerivio Coverage Across U.S. Insured Population
BRIDGEWATER, New Jersey, USA / CAESAREA, Israel, July 9, 2026 Theranica has announced a major reimbursement milestone for Nerivio®,...
Grey Matters Receives First Brain-Dedicated PET Scanner
VANCOUVER, British Columbia, July 6, 2026 Grey Matters Health Inc. announced the delivery of its first FDA-cleared CareMiBrain™ brain-dedicated...
Catheter Precision Wins Two Patents for VIVO and Cardionomix
FORT MILL, S.C., July 6, 2026 Catheter Precision, Inc. announced the issuance of two new patents covering key technologies...
GT Medical Technologies Announces GammaTile Improves Survival and Reduces Recurrence in Brain Metastases
TEMPE, Ariz., May 30, 2026 GT Medical Technologies announced positive Phase 3 results from the randomized multicenter ROADS clinical...
Advertisement
